AbbVie (NYSE:ABBV) today announced Phase 2 results showing adults with moderate to severe hidradenitis suppurativa (HS) who had previously failed anti-TNF therapy who received lutikizumab (ABT-981) 300 mg every other

ABBV

Escalating US Treasury Yields Reflect Intensifying Uncertainty Over Debt Ceiling Negotiations

By Piero Cingari

May 23, 8:56 AM

Treasury yields are experiencing heavy volatility as a debt ceiling agreement continues to be delayed with less than a week until the U.S.

TLT

News
Tech

Rumor: iPhone 15 Charging Cable Could Be A Whopping 1.5 Meters Long!

By Ananya Gairola

August 23, 12:59 AM

Apple's upcoming iPhone 15 is rumored to feature an unusually long 1.5-meter charging cable, potentially impacting the device's packaging and shipping costs.

AAPL

HC Wainwright & Co. Downgrades Argo Blockchain to Neutral

Related Posts

Leidos Q2: 7% Revenue Growth, Higher Demand, Raised FY23 Topline Guidance & More

AbbVie Says The Study’s Primary Endpoint Was An Achievement Of HiSCR 50 At Week 16, And The Secondary Endpoint Was Skin Pain NRS30 At Week 16 Among Subjects With Baseline NRS≥3

Escalating US Treasury Yields Reflect Intensifying Uncertainty Over Debt Ceiling Negotiations

Rumor: iPhone 15 Charging Cable Could Be A Whopping 1.5 Meters Long!